163 Results for Cardiology near Nyack, NY

Dr. Lerman's Biography — Dr. Bruce B. Lerman is the H. Altschul Master Professor of Medicine, Chief of the Division of Cardiology and Director of the Electrophysiology Laboratory at Weill-Cornell and the New York Presbyterian Hospital. He received his medical degree from Loyola University - Stritch School of Medicine, was an intern and medical resident at Northwestern University and completed his cardiology fellowship at Johns Hopkins. He trained in cardiac electrophysiology at the University of Pennsylvania. He has authored over 200 original publications, 60 book chapters and 2 books. He is a recipient of the Established Investigator Award from the American Heart Association and had received multiple grants from the NIH. He is currently on the editorial boards of Circulation, Heart Rhythm, Journal of Cardiac Electrophysiology, Pacing and Clinical Electrophysology and the Journal of Innovations in Cardiac Rhythm Management. He is a member of the exam writing committee of the American Board of Internal Medicine for the Cardiac Electrophysiology Board Examination.. His research contributions include elucidating the myriad electrophsyiologic mechanisms of the nucleoside adenosine, pioneering the concept of current-based defibrillation and determining the role of mechanoelectrical feedback as a stimulus for triggering malignant ventricular arrhythmias. His current work focuses on the the cellular and molecular mechanisms of ventricular outflow tract tachycardia. His laboratory has identified critical somatic mutations in the cAMP signal transduction cascade that mediate this form of ventricular tachycardia, thus introducing a new paradigm for the causation of ventricular tachycardia. He has been issued 4 patents. He clinical concentration focuses on the diagnosis and treatment (ablation) of complex atrial and ventricular arrhythmias, as well as on the treatment of life-threatening arrhythmias with implantable devices. For the last 15 years, he's been named in New York Magazine- Best Doctors, Castle Connolly – America's Top Doctors, US News and World Report (Best Doctors) and the New York Times (Super Doctors).

Dr. Steinberg's Biography — Dr. Leonard Steinberg, MD is a Pediatric Cardiology Specialist who practices in New York, NY. He is 62 years old and has been practicing for 29 years. Dr. Leonard Steinberg, MD is affiliated with NewYork-Presbyterian/Weill Cornell Medical Center.

Dr. Wong's Biography — Dr. S. Chiu Wong is a Professor of Medicine of the Greenberg Division of Cardiology in the Department of Medicine of the Weill Medical Colllege of Cornell University. He is the Director of Cardiac Catheterization laboratories at the New York Presbyterian- Weill Cornell Medical Center. Dr. Wong graduated Summa Cum Laude from Columbia College in May 1980 and received his Doctor of Medicine degree from Columbia University, College of Physicians and Surgeons in May 1984 . Following his medical internship, residency, and clinical cardiology training at St. Luke's/Roosevelt Medical Center in New York City, he spent one additional stent fellowship year in 1991 under the tutorage of Dr. Richard Schatz at Scripps's Clinic and Research Foundation in La Jolla, California. He is board certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology. After his medical training, Dr. Wong joined the Cardiology Research Foundation at the Washington Hospital in 1992 and was appointed as Director of Coronary Stent Program in 1993. In 1995, Dr. Wong spearheaded a new cardiac catheterization program at the New York Hospital Medical Center of Queens where he assumed the directorship of coronary interventions. In October 1999, Dr. Wong was recruited to the New York Presbyterian Hospital - Cornell Campus as Director of Cardiac Catheterization Laboratories. Dr. Wong has published extensively in the field of interventional cardiology with special focus on new device angioplasty, saphenous vein graft intervention, cardiogenic shock, and drug eluting stent. His current clinical research interests include novel drug eluting stent designs, access site and PFO closure devices, percutaneous valve repair, and application of stem cell technology in the treatment of myocardial ischemia. In the past five years, Dr. Wong and his colleagues had participated in multiple US pivotal trials that led to the FDA approval of both drug eluting stents for the treatment of symptomatic obstructive coronary artery disease. Dr. Wong has recently served as the national principal investigation in the ECLIPSE trial which evaluated the safety and efficacy of an extra-vascular bio-degradable access site closure device in patients undergoing coronary or peripheral diagnostic/interventional procedures compare to the standard treatment of manual compression. Other exciting areas of ongoing research include percutaneous treatment valvular disease states including mitral regurgitation and aortic stenosis, assessment of novel pharmacologic agents to enhance safety of angioplasty procedures. His clinical research activities have been published in Journal of American College of Cardiology, American Journal of Cardiology, American heart Journal and he has presented his findings at numerous national and international meetings including American Heart Association, American College of Cardiology, Transcatheter Therapeutics, Summer in Seattle, Taiwan Society of Cardiology and Asia Pacific Cardiology Congress. He is recruited to serve as member of the Scientific Advisory Board of multiple major US medical device companies.